Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma

NCT01473628 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Ann Arbor Stage I Grade 1 Follicular Lymphoma
Ann Arbor Stage I Grade 2 Follicular Lymphoma
Ann Arbor Stage II Grade 1 Follicular Lymphoma
Ann Arbor Stage II Grade 2 Follicular Lymphoma

Interventions

OTHER: Clinical Observation
RADIATION: Radiation Therapy
BIOLOGICAL: Rituximab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]